zinc protoporphyrin ix has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, XC; Li, HS; Liu, YS; Qi, DF; Shi, K; Zhang, J; Zhang, XH; Zhang, XJ | 1 |
| Kapoor, S | 1 |
| Gao, S; Hao, Y; Li, S | 1 |
3 other study(ies) available for zinc protoporphyrin ix and Liver Neoplasms
| Article | Year |
|---|---|
Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Heme Oxygenase-1; Hemin; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Nude; Oxidative Stress; Protoporphyrins; Reactive Oxygen Species; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
The therapeutic benefits of heme oxygenase (HO-1) inhibition in the management of systemic malignancies besides hepatocellular carcinomas.
Topics: Antineoplastic Agents; Benzamides; Carcinoma, Hepatocellular; Enzyme Inhibitors; Heme Oxygenase-1; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Neoplasms; Nasopharyngeal Neoplasms; Neoplasms; Piperazines; Protoporphyrins; Pyrimidines; Sarcoma, Kaposi | 2009 |
[Changes in hematoporphyrin in patients with gastric and hepatic carcinoma and their clinical significance].
Topics: Biomarkers, Tumor; Humans; Liver Neoplasms; Protoporphyrins; Spectrometry, Fluorescence; Stomach Neoplasms | 1996 |